Suchergebnisse - "SHI LINGFEI"

PubPharm (11)

1

Outcomes of 2-SSRS plus bevacizumab therapy strategy for brainstem metastases (BSM) over 2 cm3 : a multi-center study

enthalten in: Neurosurgical review | 2024

von Wang, Z. | Chen, H. | Chen, Q. | +4

2

Outcomes of 2-SSRS plus bevacizumab therapy strategy for brainstem metastases (BSM) over 2 $ cm^{3} $: a multi-center study

enthalten in: Neurosurgical review | 2024

von Wang, Z. | Chen, H. | Chen, Q. | +4

3

Association of low-level blood lead with plasma homocysteine in US children and adolescents

enthalten in: Environmental geochemistry and health | 2023

von Shi, L. | Zhou, J. | Dong, J. | +2

4

Immunoregulatory cantharidin magnetic response nano-drug and preparation method thereof

enthalten in: Europäisches Patentamt | 2023

von SHI LINGFEI | ZHOU JIA | LI MIN | +1

5

Immunoregulatory cantharidin magnetic response nano-drug and preparation method thereof

enthalten in: Europäisches Patentamt | 2023

von SHI LINGFEI | ZHOU JIA | LI MIN | +1

6

Seasonal SUHI Analysis Using Local Climate Zone Classification : A Case Study of Wuhan, China

enthalten in: International journal of environmental research and public health | 2021

von Shi, L. | Ling, F. | Foody, G. | +3

7

Chronic virus carrier carrying CXXC4 gene and application thereof

enthalten in: Europäisches Patentamt | 2020

von ZHOU JIA | SHI LINGFEI | LI MIN | +1

8

PEGFP-N1-CXXC4 eukaryotic expression plasmid, and construction method and application thereof

enthalten in: Europäisches Patentamt | 2020

von SHI LINGFEI | ZHOU JIA | LI MIN | +1

9

Transient increase in international normalized ratio (INR) and bleeding risk following Alendronate sodium in elderly patients on warfarin : Two case reports

enthalten in: Medicine | 2020

von Qian, S. | Zhou, J. | Bian, P. | +1

10

Efficacy and Safety of Gamma Knife Radiosurgery for Meningiomas in Patients with Neurofibromatosis Type 2 : A Long-Term Follow-Up Single-Center Study

enthalten in: World neurosurgery | 2019

von Gao, F. | Li, M. | Wang, Z. | +3